Diaceutics (DXRX.L) Stock Analysis & Winston Score

Diaceutics is a data and analytics company that helps pharmaceutical companies get the right diagnostic tests used before patients start treatment. When a new drug only works for patients with a specific genetic marker, Diaceutics helps drug makers understand how well labs and doctors are actually running those tests. Their main customers are large pharmaceutical and biotech companies launching precision medicines. The company makes money by selling data subscriptions and consulting services, drawing on a network of diagnostic lab data from over 30 countries. It is headquartered in Belfast, Northern Ireland, and operates globally, with its core advantage being one of the largest proprietary databases of real-world diagnostic testing behavior in the industry. The key growth driver is the continued expansion of precision medicine, where more drugs require companion diagnostic tests before prescribing — but with a small market cap and near-zero operating margins, the company must scale revenue faster than costs to reach sustainable profitability.